Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection.

Autor: Carvajal LP; Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombia., Rincon S; Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombia., Gomez Villegas SI; Brigham and Women´s Hospital, Harvard Medical School, Boston, Massachusetts, USA., Matiz-Gonzalez JM; Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombia., Ordoñez K; Department of Infectious Diseases, ESE Hospital Universitario,San Jorge de Pereira, Pereira, Colombia., Santamaria A; Department of Infectious Diseases, ESE Hospital Universitario,San Jorge de Pereira, Pereira, Colombia., Ospina Navarro L; Clinica Colsubsidio Calle, Bogota, Colombia., Beltran J; Clinica Colsubsidio Calle, Bogota, Colombia., Guevara F; Servicio de Infectología, Fundación Santafe de Bogota, Bogota, Colombia.; Clinica Reina Sofia, Colsanitas, Bogota, Colombia., Mendez YR; Grupo de Investigacion en Epidemiologia Clinica de Colombia (GRECO), Universidad Pedagogica y Tecnologica de Colombia, Tunja, Colombia.; Hospital Regional de Duitama, Duitama, Colombia., Salcedo S; Organizacion Clinica General del Norte, Barranquilla, Colombia., Porras A; Los Cobos Medical Center, Bogota, Colombia., Valencia-Moreno A; Los Cobos Medical Center, Bogota, Colombia., Greenia H; Center for Infectious Disease, Houston Methodist Research Institute, Houston, Texas, USA., Deyanov A; Center for Infectious Disease, Houston Methodist Research Institute, Houston, Texas, USA., Baptista R; Center for Infectious Disease, Houston Methodist Research Institute, Houston, Texas, USA.; Division of Infectious Diseases and Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Tam VH; Departament of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA., Panesso D; Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombia.; Center for Infectious Disease, Houston Methodist Research Institute, Houston, Texas, USA.; Division of Infectious Diseases and Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Tran TT; Center for Infectious Disease, Houston Methodist Research Institute, Houston, Texas, USA.; Division of Infectious Diseases and Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Miller WR; Center for Infectious Disease, Houston Methodist Research Institute, Houston, Texas, USA.; Division of Infectious Diseases and Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Arias CA; Center for Infectious Disease, Houston Methodist Research Institute, Houston, Texas, USA.; Division of Infectious Diseases and Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Reyes J; Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombia.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Nov 06; Vol. 68 (11), pp. e0089824. Date of Electronic Publication: 2024 Sep 30.